RecallDepth
Class II Terminated

Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC 0904-7043-04 and b) 100 Unit Doses (10x10 blister packs) NDC 0904-7043-61, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA.

This recall has been terminated (originally issued February 5, 2025).

Company
The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
Recall Initiated
January 13, 2025
Posted
February 5, 2025
Recall Number
D-0212-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 6408 boxes and b)1488 boxes
Firm Location
La Vergne, TN, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: a) N01530, Exp. Date 01/2025; b) N01540, Exp. Date. 01/2025

More recalls by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories

View all recalls by this company →

Other recent Class II Drug recalls